FRIDAY, July 26, 2024 -- For adolescent girls and young women, lenacapavir every 26 weeks is beneficial for preventing acquired HIV infection, according to a study published online July 24 in the
New England Journal of Medicine
to coincide with the 25th International AIDS Conference, held from July 22 to 26 in Munich.
Linda-Gail Bekker, M.B., Ch.B., Ph.D., from the Desmond Tutu HIV Centre at the University of Cape Town in South Africa, and colleagues conducted a phase 3 trial involving adolesce